IIM
DXCM icon

IFC & Insurance Marketing’s DexCom DXCM Stock Holding History

IFC & Insurance Marketing’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-59
Closed -$4K – 220
2025
Q4 		$4K Buy
+59
New +$3.81K ﹤0.01% 542

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

IFC & Insurance Marketing's DXCM Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of DexCom (DXCM) in Q1 2026, closing a stake of 59 shares — an estimated $4K sold.

IFC & Insurance Marketing first reported a position in DXCM in Q4 2025 and held it in 1 quarter. The position peaked at $4K in Q4 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • IFC & Insurance Marketing reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
  • IFC & Insurance Marketing sold 59 DexCom shares in Q1 2026, an estimated $4K.
  • IFC & Insurance Marketing first reported a position in DexCom in Q4 2025 and held it in 1 quarter.
  • IFC & Insurance Marketing's DexCom position peaked at $4K in Q4 2025.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.